SCHEMBL7817854

SCHEMBL7817854

O=C(c1ccccc1Cl)N1CC(CO)C(c2ccccc2)C1

nearest known ligand 0.68

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 13/20 0.68
P2RX7 Q99572 2/20 0.53
RAB9A P51151 1/20 0.50
RXFP1 Q9HBX9 1/20 0.49
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
HTR2B P41595 1/20 0.48
MAPK14 Q16539 1/20 0.48
TLR2 O60603 1/20 0.46
TLR1 Q15399 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7829652 0.82 CCR5 (0.69) CCR5
SCHEMBL7839226 0.81 CCR5 (1.00) CCR5
SCHEMBL4099146 0.80 CCR5 (0.48) CCR5
SCHEMBL7826402 0.79 CCR5 (0.56) CCR5P2RX7RAB9ARXFP1CYP2C9
SCHEMBL4108008 0.77 CCR5 (0.46) CCR5
SCHEMBL7882945 0.77 CCR5 (0.46) CCR5
SCHEMBL13104864 0.75 NMT1 (0.50) CCR5HTR2B
SCHEMBL4113345 0.74 CCR5 (0.51) CCR5P2RX7
SCHEMBL7836168 0.74 CCR5 (0.86) CCR5
SCHEMBL4108855 0.74 KDM1A (0.48) CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1009405-A4 PYRROLIDINE AND PIPERIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO INC (US) 2001-05-09 EP disclosed
US-6166037-A Pyrrolidine and piperidine modulators of chemokine receptor activity MERCK & CO., INC. (US) 2000-12-26 US disclosed
EP-1009405-A1 PYRROLIDINE AND PIPERIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Merck & Co., Inc. (US) 2000-06-21 EP disclosed
WO-1999009984-A1 PYRROLIDINE AND PIPERIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 1999-03-04 WO disclosed